Hormones and bone loss across the menopause transition

Area of Science:

• Reproductive Endocrinology
• Bone Biology
• Gerontology

Background:

• Menopause transition significantly impacts women's bone health.
• Rapid bone loss occurs in a 3-year window around the final menstrual period.
• Sex steroid hormone changes precede and potentially predict this rapid bone loss phase.

Purpose of the Study:

• To evaluate the clinical utility of sex hormone levels in predicting bone loss during menopause.
• To determine if hormone measurements can identify women entering the rapid bone loss phase.
• To assess if hormone levels predict the extent of bone mass loss during menopause.

Main Methods:

• Review of recent and new findings on sex hormone levels and bone loss.
• Analysis of hormone measurements in women in their 5th decade.
• Correlation of hormone levels with the onset and rate of bone mass loss.

Main Results:

• Sex hormone levels show potential in identifying the onset of rapid bone loss.
• Hormone measurements can help predict women likely to experience greater than average bone mass reduction.
• These findings support the clinical use of hormone measurements for personalized bone health strategies.

Conclusions:

• Sex hormone levels are valuable biomarkers for predicting bone loss trajectory during menopause.
• Monitoring hormone changes can aid in early intervention for osteoporosis prevention.
• Clinical application of these findings can improve management of menopausal bone health.